Effentora

Effentora is a buccal fentanyl tablet used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal use.

Effentora is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for persistent pain. It is designed to be placed between the cheek and gum, where it dissolves to deliver fentanyl, a potent opioid analgesic. This medication is not intended for use in opioid-naive patients or for the treatment of mild or intermittent pain.

Common effects of Effentora may include drowsiness, dizziness, nausea, and headache. Some users may experience constipation or dry mouth. These effects can vary in intensity and duration depending on individual factors.

Effentora should be handled with care to avoid accidental exposure. It is important to store the medication securely to prevent misuse. Patients should be aware of the risks of respiratory depression and sedation, especially when starting treatment or increasing the dose.

Effentora may interact with other medications, including other opioids, benzodiazepines, and alcohol. These interactions can enhance the sedative effects and increase the risk of respiratory depression. It is advisable to consult a healthcare provider before combining Effentora with other medications.